|
End-of-day quote
Shenzhen S.E.
2026-10-30
|
5-day change | 1st Jan Change | ||
| 8.070 CNY | +1.00% |
|
-0.25% | +1.64% |
| Market Cap | 4.69B 705M 632M 581M 526M 984M 66.97B 1B 6.93B 2.78B 35.23B 2.65B 2.59B 111B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.53B 680M 609M 560M 508M 949M 64.56B 966M 6.68B 2.68B 33.96B 2.55B 2.5B 107B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +1.00% | ||
| 1 week | -0.25% | ||
| 1 month | -15.59% | ||
| 3 months | +3.33% | ||
| 6 months | -14.78% | ||
| Current year | +1.64% |
| 1 week | 7.6 |  | 8.41 |
| 1 month | 7.58 | | 9.63 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 2017-12-10 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 2019-07-31 |
Sen Li
COO | Chief Operating Officer | 45 | 2022-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 2019-07-31 |
Ying Yang
CHM | Chairman | 48 | 2019-03-20 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 2019-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.00% | -0.25% | -8.92% | +11.46% | 705M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.98% | +5.33% | +41.03% | +77.25% | 426.26B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.50% | +100.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 148M 132M 122M 110M 206M 14.03B 210M 1.45B 583M 7.38B 555M 543M 23.28B | 1.21B 181M 162M 149M 135M 253M 17.19B 257M 1.78B 714M 9.04B 680M 665M 28.52B |
| Net income | 13.65M 2.05M 1.84M 1.69M 1.53M 2.86M 195M 2.92M 20.15M 8.09M 102M 7.7M 7.53M 323M | 92.73M 13.93M 12.48M 11.48M 10.4M 19.44M 1.32B 19.8M 137M 54.95M 696M 52.29M 51.18M 2.19B |
| Net Debt | 189M 28.41M 25.44M 23.4M 21.21M 39.64M 2.7B 40.38M 279M 112M 1.42B 107M 104M 4.47B | -169M -25.36M -22.72M -20.89M -18.93M -35.39M -2.41B -36.05M -249M -100M -1.27B -95.18M -93.16M -4B |
Employees
1,188
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | CN¥8.070 | +1.00% | 36,174,133 |
| 26-10-29 | CN¥7.990 | -0.99% | 21,900,700 |
| 26-10-28 | CN¥8.070 | +6.04% | 30,167,549 |
| 26-10-27 | CN¥7.610 | -5.47% | 26,431,000 |
| 26-10-26 | CN¥8.050 | -0.49% | 21,064,342 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
